NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide

Published facts

What the notice says

Buyer

NHS England

Published status

complete

Latest release reference

050525-2026

CPV codes

Common Procurement Vocabulary (CPV) codes: 33600000

Published tags

award, contract

Latest record Bidwake loaded from this source

27 Aug 2026

NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028

Open the official Find a Tender notice

Observed notice trail

How the published record developed

Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.

1. Planning notice observed

   21 May 2025

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   024360-2025

   Published tags

   planning

2. Planning notice observed

   23 Jan 2026

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   006070-2026

   Published tags

   planning

3. Tender notice observed

   5 Feb 2026

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

   Record references

   Release reference

   010573-2026

   Published tags

   tender

4. Award notice observed

   26 Mar 2026

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Find a Tender notice

Awards and suppliers

Published award and contract facts

• NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide

  Buyer: NHS EnglandSupplier: AMAROX LIMITED

  End date in notice

  31 May 2028Date from the linked contract

  Value shown in notice

  £19,595,208Value from the linked contract

  Official source

  Open the official Find a Tender notice for NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide

  About this figure

  • This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
  • This figure comes from the linked contract record. Overall totals continue to use the separately published award value.

  View record references

  Source

  Find a Tender

  Award or lot reference

  1

• NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide

  Buyer: NHS EnglandSupplier: Accord UK Ltd

Related evidence

Published terms and linked processes

• Renewal information is statedLot 1Repeated in 2 notices; the most recent statement is shown.Published 23 Jan 2026.Open supporting notice 006070-2026
• Options are statedLot 1

  option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

  Published 5 Feb 2026.Open supporting notice 010573-2026
• Renewal information is statedLot 1

  option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

  Published 5 Feb 2026.Open supporting notice 010573-2026
• Options are statedLot 2

  option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

  Published 5 Feb 2026.Open supporting notice 010573-2026
• Renewal information is statedLot 2

  option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

  Published 5 Feb 2026.Open supporting notice 010573-2026
• Options are statedLot 3

  option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

  Published 5 Feb 2026.Open supporting notice 010573-2026
• Renewal information is statedLot 3

  option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.

  Published 5 Feb 2026.Open supporting notice 010573-2026

No exact source-published process relationship was found.